Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial

Hepatitis C virus genotype 2 (HCV-2) slow responders poorly respond to 24 weeks of peginterferon (Peg-IFN) plus ribavirin (RBV). We evaluated the efficacy of extended 48-week regimen and the role of interleukin-28B (IL-28B) genotype in this clinical setting. Treatment-naïve HCV-2 patients not achiev...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Liu, Chen-Hua, Huang, Chung-Feng, Liu, Chun-Jen, Dai, Chia-Yen, Huang, Jee-Fu, Lin, Jou-Wei, Liang, Cheng-Chao, Yang, Sheng-Shun, Lin, Chih-Lin, Su, Tung-Hung, Yang, Hung-Chih, Chen, Pei-Jer, Chen, Ding-Shinn, Chuang, Wan-Long, Kao, Jia-Horng, Yu, Ming-Lung
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486927/
https://ncbi.nlm.nih.gov/pubmed/26130141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep11710
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы